(Q44340325)

2 December 2017

title

Targeting the opioid growth factor: opioid growth factor receptor axis for treatment of human ovarian cancer (English)

1 reference

2 December 2017

0 references

1 reference

Ian S Zagon

1

1 reference

2 December 2017

Renee Donahue

series ordinal

2

1 reference

2 December 2017

Patricia J McLaughlin

series ordinal

3

1 reference

2 December 2017

publication date

1 May 2013

1 reference

Experimental Biology and Medicine

2 December 2017

published in

1 reference

2 December 2017

volume

238

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

579-587

1 reference

Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Endocrine signaling in ovarian surface epithelium and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

CA 125 and the detection of recurrent ovarian cancer: a reasonably accurate biomarker for a difficult disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Increased brain size and cellular content in infant rats treated with an opiate antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Endogenous opioid systems regulate cell proliferation in the developing rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Distribution of enkephalin immunoreactivity in germinative cells of developing rat cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

An opioid growth factor regulates the replication of microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Studies of the in vitro human plasma degradation of methionine-enkephalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Naltrexone modulates body and brain development in rats: A role for endogenous opioid systems in growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: a role for endogenous opioid systems in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Opioid antagonist-induced regulation of organ development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Modulation of murine neuroblastoma in nude mice by opioid antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Naloxone modulates body and organ growth of rats: dependency on the duration of opioid receptor blockade and stereospecificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Opioid antagonist (naltrexone) stimulation of cell proliferation in human and animal neuroblastoma and human fibrosarcoma cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Characterization of opioid binding sites in murine neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Characterization of zeta (zeta): a new opioid receptor involved in growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Demonstration and characterization of zeta (zeta), a growth-related opioid receptor, in a neuroblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Zeta (zeta), a growth-related opioid receptor in developing rat cerebellum: identification and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Zeta (zeta), the opioid growth factor receptor: identification and characterization of binding subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Cloning, sequencing, expression and function of a cDNA encoding a receptor for the opioid growth factor, [Met(5)]enkephalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Molecular characterization and distribution of the opioid growth factor receptor (OGFr) in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

The biology of the opioid growth factor receptor (OGFr)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Dependence on nuclear localization signals of the opioid growth factor receptor in the regulation of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Defects in the opioid growth factor receptor in human squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Expression of the opioid growth factor-opioid growth factor receptor axis in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Gene-peptide relationships in the developing rat brain: the response of preproenkephalin mRNA and [Met5]-enkephalin to acute opioid antagonist (naltrexone) exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Modulation of the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: novel therapies for squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

Treatment of advanced pancreatic cancer with opioid growth factor: phase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488483

21 January 2018

Identifiers

DOI

10.1177/1535370213488483

1 reference

2 December 2017

1 reference